HealthDay - WEDNESDAY, July 11 (HealthDay News) — A study in rats suggests thatthe anti-obesity drug rimonabant may also reduce liver damage and improvecholesterol levels.
More: continued here
You can respond, or trackback from your own site.
Name (required)
Mail (will not be published) (required)
Website